Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Regno Unito
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. SocietÓ
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietÓFinanzaConsensusRevisioniDerivati 
AttivitÓ
Logo GlaxoSmithKline plc
GlaxoSmithkline plc Ŕ il secondo gruppo farmaceutico al mondo. Le vendite nette sono ripartite per famiglia di prodotti come segue:

- prodotti farmaceutici (50%): destinati a malattie respiratorie (64,9% delle vendite nette), infezioni da HIV (28,6%), disturbi del sistema immunitario (4,3%) ) e cancro (2,2%)

- OTC e medicina parafarmaceutica (29,4%)

- vaccini (20,5%)

- altro (0,1%)

Le vendite nette sono distribuite geograficamente come segue: Regno Unito (2,9%), Stati Uniti (42,7%) e altri (54,4%).

Numero di dipendenti : 94 066 persone.
Vendite per attivitÓ
20192020Delta
Pharmaceuticals17 554.0052%17 056.0050% -2.84%
Consumer Healthcare8 995.0026.6%10 033.0029.4% +11.54%
Vaccines7 157.0021.2%6 982.0020.5% -2.45%
Corporate and Other Unallocated48.000.1%28.000.1% -41.67%
GBP in Milioni
Vendite per regione
20192020Delta
United States13 890.0041.2%14 556.0042.7% +4.79%
Rest of World11 795.0034.9%11 379.0033.4% -3.53%
Europe7 127.0021.1%7 184.0021.1% +0.8%
United Kingdom942.002.8%980.002.9% +4.03%
GBP in Milioni
Dirigenti
Nome Titolo EtÓ Da
Emma Walmsley Chief Executive Officer & Executive Director 51 2017
Iain Mackay Chief Financial Officer & Executive Director 59 2019
Karenann Terrell Chief Digital & Technology Officer 58 2017
Hal Barron Executive Director & Chief Scientific Officer 57 2018
Jon Ellis VP & Head-Technology Business Development 53 2019
Amy Altshul SVP-Legal, Research & Development - -
Romulo Colindres VP-Global Medical Affairs Lead for Zoster 49 -
Lynn Laverty Elsenhans Independent Non-Executive Director 63 2012
Urs Rohner Independent Non-Executive Director 61 2015
Manvinder Singh Banga Senior Independent Non-Executive Director 65 2016
Amministratori
Nome Titolo EtÓ Da
Jonathan Symonds Non-Executive Chairman 61 2019
Emma Walmsley Chief Executive Officer & Executive Director 51 2017
Lynn Laverty Elsenhans Independent Non-Executive Director 63 2012
Urs Rohner Independent Non-Executive Director 61 2015
Manvinder Singh Banga Senior Independent Non-Executive Director 65 2016
Jesse L. Goodman, Dr. Independent Non-Executive Director 68 2016
Vivienne Cox Independent Non-Executive Director 61 2016
Laurie H. Glimcher, Dr. Independent Non-Executive Director 68 2017
Hal Barron Executive Director & Chief Scientific Officer 57 2018
Iain Mackay Chief Financial Officer & Executive Director 59 2019
Azioni
Voto QuantitÓFlottanteAutocontrolloFlottante totale
Azione A 1 5 386 937 397 4 968 070 912 92.2% 355 205 950 6.6% 92.2%
Azionisti
NomeAzioni%
The Vanguard Group, Inc. 151 654 522 3,01%
BlackRock Fund Advisors 131 211 690 2,61%
Norges Bank Investment Management 117 972 000 2,34%
Dodge & Cox 99 377 874 1,98%
Capital Research & Management Co. (Global Investors) 81 077 927 1,61%
BlackRock Advisors (UK) Ltd. 69 356 000 1,38%
Schroder Investment Management Ltd. 67 445 105 1,34%
State Street Global Advisors Ltd. 66 345 263 1,32%
Threadneedle Asset Management Ltd. 57 003 962 1,13%
Silchester International Investors LLP 56 966 000 1,13%
Partecipazioni
NomeAzioni%Valorizzazione
LYELL IMMUNOPHARMA, INC. (LYEL) 30 253 189 12,6% 477 697 854 USD
VIR BIOTECHNOLOGY, INC. (VIR) 6 626 027 5,07% 341 505 432 USD
GLAXOSMITHKLINE PAKISTAN LIMITED (GLAXO) 263 029 794 82,6% 257 006 412 USD
GLAXOSMITHKLINE CONSUMER HEALTHCARE PAKISTAN LIMITED (GSKCH) 100 423 259 85,8% 165 681 305 USD
GLAXOSMITHKLINE S.A.E (BIOC) 76 161 378 91,2% 151 788 865 USD
THERAVANCE BIOPHARMA, INC. (TBPH) 9 644 807 13,1% 80 051 898 USD
BICYCLE THERAPEUTICS LIMITED 1 529 561 7,18% 54 605 328 USD
FULCRUM THERAPEUTICS, INC. (FULC) 1 785 714 4,43% 53 035 706 USD
DONG-A SOCIO HOLDINGS CO., LTD. (A000640) 409 693 6,45% 40 635 384 USD
ALLERGY THERAPEUTICS PLC (AGY) 10 118 000 1,58% 4 609 154 USD
Mercati e indici
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Codici di Borsa
- Codice Bloomberg :  GSK:LN
- Codice Reuters :  GSK.L
- Codice Datastream :  GSK
Coordinate societÓ
GlaxoSmithKline plc
980 Great West Road
TW8 9GS Brentford, Greater London

Telefono : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pi¨ marchi di GlaxoSmithKline plc
Settore Prodotti farmaceutici - Altri
Var. 1genCapi. (M$)
GLAXOSMITHKLINE PLC3.37%95 179
JOHNSON & JOHNSON3.68%429 542
ROCHE HOLDING AG9.24%319 352
PFIZER, INC.19.37%244 283
NOVO NORDISK A/S48.08%227 557
ELI LILLY AND COMPANY34.09%205 250
ABBVIE INC.0.53%190 360
MERCK & CO., INC.-10.32%185 702
NOVARTIS AG-8.36%185 289
ASTRAZENECA PLC16.97%181 937
BRISTOL-MYERS SQUIBB COMPANY-3.53%132 971
AMGEN INC.-7.31%121 015
SANOFI4.35%120 616
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.17%62 650
BAYER AG-1.79%54 369
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.43%53 442
DAIICHI SANKYO COMPANY, LIMITED-12.76%53 264
JIANGSU HENGRUI MEDICINE CO., LTD.-45.36%50 085
ASTELLAS PHARMA INC.17.63%31 313
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY50.32%24 839